Evidence map›Paper›PMID 36443693›Full record

ArticleBMC cancer2022

Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of "waiting time": a preliminary report.

Cheng-Yu Liao, Dan-Feng Wang, Bin-Hua Jiang, Long Huang, Tian-Sheng Lin, Fu-Nan Qiu, Song-Qiang Zhou, Yao-Dong Wang, Xiao-Chun Zheng, Yi-Feng Tian and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Cheng-Yu Liao *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Dan-Feng Wang *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Bin-Hua Jiang *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Long HuangShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Tian-Sheng LinShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Fu-Nan QiuShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Song-Qiang ZhouShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Yao-Dong WangShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Xiao-Chun ZhengShengli Clinical Medical College of Fujian Medical University, Fuzhou, China. fjslyymzk@126.com.
Yi-Feng TianShengli Clinical Medical College of Fujian Medical University, Fuzhou, China. yifengtian123@126.com.
Shi ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou, China. wawljwalj@163.com.
Fujian Medical University · CNFujian Provincial Hospital · CN

Funding

Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare 2021(60)
6 · The paper itself

Abstract

introductionClinicians increasingly perform laparoscopic surgery for intrahepatic cholangiocarcinoma (ICC). However, this surgery can be difficult in patients with advanced-stage ICC because of the complicated procedures and difficulty in achieving high-quality results. We compared the effects of a three-step optimized procedure with a traditional procedure for patients with advanced-stage ICC.

methodsForty-two patients with advanced-stage ICC who received optimized laparoscopic hemihepatectomy with lymph node dissection (LND, optimized group) and 84 propensity score-matched patients who received traditional laparoscopic hemihepatectomy plus LND (traditional group) were analyzed. Surgical quality, disease-free survival (DFS), and overall survival (OS) were compared.

resultsThe optimized group had a lower surgical bleeding score (P = 0.038) and a higher surgeon satisfaction score (P = 0.001). Blood loss during hepatectomy was less in the optimized group (190 vs. 295 mL, P < 0.001). The optimized group had more harvested LNs (12.0 vs. 8.0, P < 0.001) and more positive LNs (8.0 vs. 5.0, P < 0.001), and a similar rate of adequate LND (88.1% vs. 77.4%, P = 0.149). The optimized group had longer median DFS (9.0 vs. 7.0 months, P = 0.018) and median OS (15.0 vs. 13.0 months, P = 0.046). In addition, the optimized group also had a shorter total operation time (P = 0.001), shorter liver resection time (P = 0.001), shorter LND time (P < 0.001), shorter hospital stay (P < 0.001), and lower incidence of total morbidities (14.3% vs. 36.9%, P = 0.009).

conclusionsOur optimization of a three-step laparoscopic procedure for advanced ICC was feasible, improved the quality of liver resection and LND, prolonged survival, and led to better intraoperative and postoperative outcomes.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaLaparoscopyBile Ducts, IntrahepaticHepatectomyHumansHemihepatectomyIntrahepatic cholangiocarcinomaLaparoscopicLymph node dissectionOptimization

Identifiers

PMID36443693
PMCPMC9703772
OpenAlexW4310223464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.